These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 28809443

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. The pharmacokinetics of valproic acid in pregnant sheep after maternal and fetal intravenous bolus administration.
    Gordon JD, Riggs KW, Rurak DW, Kwan E, Hall C, Abbott FS.
    Drug Metab Dispos; 1995 Dec; 23(12):1383-9. PubMed ID: 8689948
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Circadian variation of Valproic acid pharmacokinetics in mice.
    Ben-Cherif W, Dridi I, Aouam K, Ben-Attia M, Reinberg A, Boughattas NA.
    Eur J Pharm Sci; 2013 Jul 16; 49(4):468-73. PubMed ID: 23707469
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Plasma and cerebrospinal fluid pharmacokinetics of valproic acid after oral administration in non-human primates.
    Stapleton SL, Thompson PA, Ou CN, Berg SL, McGuffey L, Gibson B, Blaney SM.
    Cancer Chemother Pharmacol; 2008 Apr 16; 61(4):647-52. PubMed ID: 17541590
    [Abstract] [Full Text] [Related]

  • 31. Influence of nanoparticles on the brain-to-serum distribution and the metabolism of valproic acid in mice.
    Darius J, Meyer FP, Sabel BA, Schroeder U.
    J Pharm Pharmacol; 2000 Sep 16; 52(9):1043-7. PubMed ID: 11045883
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. A population pharmacokinetic model of valproic acid in pediatric patients with epilepsy: a non-linear pharmacokinetic model based on protein-binding saturation.
    Ding J, Wang Y, Lin W, Wang C, Zhao L, Li X, Zhao Z, Miao L, Jiao Z.
    Clin Pharmacokinet; 2015 Mar 16; 54(3):305-17. PubMed ID: 25388986
    [Abstract] [Full Text] [Related]

  • 34. Nanoemulsions for Intranasal Delivery of Riluzole to Improve Brain Bioavailability: Formulation Development and Pharmacokinetic Studies.
    Parikh RH, Patel RJ.
    Curr Drug Deliv; 2016 Mar 16; 13(7):1130-1143. PubMed ID: 26638977
    [Abstract] [Full Text] [Related]

  • 35. Neuropharmacokinetic evaluation of lactoferrin-treated indinavir-loaded nanoemulsions: remarkable brain delivery enhancement.
    Karami Z, Saghatchi Zanjani MR, Rezaee S, Rostamizadeh K, Hamidi M.
    Drug Dev Ind Pharm; 2019 May 16; 45(5):736-744. PubMed ID: 30640551
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Anticonvulsant profile and teratogenicity of 3,3-dimethylbutanoylurea: a potential for a second generation drug to valproic acid.
    Shimshoni JA, Yagen B, Pessah N, Wlodarczyk B, Finnell RH, Bialer M.
    Epilepsia; 2008 Jul 16; 49(7):1202-12. PubMed ID: 18435754
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.